Neoadjuvant Immunochemotherapy for LAOSCC
Clinical trial NCT06258811 · RECRUITING
Trial details
- NCT number
- NCT06258811
- Sponsor
- Lai-ping Zhong
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-20
- Primary completion
- 2026-12-30
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.